Quality of T-cell responses versus reduction in viral load: results from an exploratory phase II clinical study of Vacc-4x, a therapeutic HIV vaccine

• Ellefsen-Lavoie K,
• Rockstroh J,
• Pollard R,
• Pantaleo G,
• Podzamczer D,
• Asmuth D,
• van Lunzen J,
• Arastéh K,
• Schürmann D,
• Peters B,
• Clotet B,
• Hardy D,
• Lazzarin A,
• Gatell J,
• Sommerfelt MA,
• Baksaas I,
• Wendel-Hansen V,
• Sørensen B

Affiliations

Ellefsen-Lavoie K

Rockstroh J

Pollard R

Pantaleo G

Podzamczer D

Asmuth D

van Lunzen J

Arastéh K

Schürmann D

Peters B

Clotet B

Hardy D

Lazzarin A

Gatell J

Sommerfelt MA

Baksaas I

Wendel-Hansen V

Sørensen B